 |
This article does not cite any references or sources. (December 2009) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (8β)- 6-methyl- 8- (pyrrolidin- 1- ylcarbonyl)- 9,10- didehydroergoline | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| CAS number | 2385-87-7 |
| ATC code | ? |
| PubChem | CID 200628 |
| ChemSpider | 173678  |
| ChEMBL | CHEMBL302524 |
| Synonyms | LPD-824, N-Pyrrolidyl-lysergamide |
| Chemical data | |
| Formula | C20H23N3O |
| Mol. mass | 321.43 g/mol |
|
|
|
|
 (what is this?) (verify) |
|
N-Pyrrolidyllysergamide (LPD-824) is a derivative of ergine. It is reported to have some mild, short lasting LSD-like effects at a dose of 800 micrograms. The use of LPD-824 has had a minor spike between 2006 and 2007 but after this time frame, virtually no reports of LPD-824 use have been documented.
 |
This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
Original courtesy of Wikipedia: http://en.wikipedia.org/wiki/LPD-824 — Please support Wikipedia.
A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.
A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.
